Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2025

Caitlin E. Cox

July 31, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Opinion CV Team Dispatch

July 2025 Dispatch for the CV Team

L.A. McKeown

July 24, 2025

News Opinion CV Team Dispatch

June 2025 Dispatch for the CV Team

L.A. McKeown

June 26, 2025

News Daily News

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Michael O'Riordan

June 25, 2025

No Change in HF Outcomes When Private Equity Buys the Hospital

News Daily News

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Michael O'Riordan

June 16, 2025

News Daily News

Majority of US Adults Have High Long-term Risk of CVD: NHANES

Michael O'Riordan

June 13, 2025

News Opinion CV Team Dispatch

May 2025 Dispatch for the CV Team

L.A. McKeown

May 20, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Conference News ACC 2025

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

L.A. McKeown

April 03, 2025

News Conference News ACC 2025

Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP

Michael O'Riordan

April 01, 2025

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

L.A. McKeown

March 21, 2025

News Daily News

Finerenone Cuts Intensification of Oral Diuretics in Outpatient Setting: FINEARTS-HF

Michael O'Riordan

March 03, 2025

News Conference News THT 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Todd Neale

February 12, 2025

News Opinion CV Team Dispatch

February 2025 Dispatch for the CV Team

L.A. McKeown

February 01, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Daily News

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

Michael O'Riordan

January 13, 2025

News Daily News

Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review

Todd Neale

January 09, 2025

News Opinion Editor's Corner

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Shelley Wood

January 01, 2025

Advertisement

TCTMD’s Top 10 Most Popular Stories for July 2025

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

July 2025 Dispatch for the CV Team

June 2025 Dispatch for the CV Team

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Majority of US Adults Have High Long-term Risk of CVD: NHANES

May 2025 Dispatch for the CV Team

April 2025 Dispatch for the CV Team

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP

March 2025 Dispatch for the CV Team

Finerenone Cuts Intensification of Oral Diuretics in Outpatient Setting: FINEARTS-HF

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

February 2025 Dispatch for the CV Team

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content